Consolidated Statement Of Income

STELLA PHARMA CORPORATION - Filing #7350910

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Consolidated statement of income
Statement of income
Net sales
200,193,000 JPY
175,169,000 JPY
Operating expenses
Selling, general and administrative expenses
629,650,000 JPY
662,340,000 JPY
Cost of sales
37,512,000 JPY
15,834,000 JPY
Operating expenses
Gross profit (loss)
162,681,000 JPY
159,334,000 JPY
Ordinary profit (loss)
-466,654,000 JPY
-480,498,000 JPY
Operating profit (loss)
-466,969,000 JPY
-503,005,000 JPY
Net sales
Non-operating income
Interest income
1,079,000 JPY
1,074,000 JPY
Other
478,000 JPY
7,000 JPY
Non-operating income
4,237,000 JPY
26,084,000 JPY
Selling, general and administrative expenses
Cost of sales
Non-operating expenses
Interest expenses
1,578,000 JPY
2,000,000 JPY
Other
JPY
81,000 JPY
Non-operating expenses
3,922,000 JPY
3,577,000 JPY
Share issuance costs
2,344,000 JPY
JPY
Extraordinary losses
768,000 JPY
JPY
Profit (loss) before income taxes
-467,422,000 JPY
-480,498,000 JPY
Gross profit
Income taxes - current
2,138,000 JPY
2,722,000 JPY
Extraordinary losses
Loss on retirement of non-current assets
768,000 JPY
JPY
Income taxes
2,138,000 JPY
2,722,000 JPY
Profit (loss)
-469,561,000 JPY
-483,220,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.